Impact of the MIC of Piperacillin-Tazobactam on the Outcome of Patients with Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Escherichia coli

We investigated the impact of the piperacillin-tazobactam MIC in the outcome of 39 bloodstream infections due to extended-spectrum-β-lactamase-producing Escherichia coli. All 11 patients with urinary tract infections survived, irrespective of the MIC. For other sources, 30-day mortality was lower fo...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Retamar, Pilar, López-Cerero, Lorena, Muniain, Miguel Angel, Pascual, Álvaro, Rodríguez-Baño, Jesús
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2013
Témata:
Clinical Therapeutics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3697383/
https://ncbi.nlm.nih.gov/pubmed/23612190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00135-13
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky